LY3437943 demonstrated a safety and tolerability profile equivalent to other incretins in a phase 1 single ascending dosage study
Unwavering Confidence from Novo Nordisk: Despite emerging concerns, Novo Nordisk firmly backs Ozempic's safety and efficacy, vowing persistent surveillance and cooperation with regulatory bodies to ensure ongoing patient safety
If you are considering berberine, especially if you take prescription medications or have diabetes, kidney disease, liver disease, cardiovascular disease, or are pregnant or breastfeeding, discuss it with your clinician first
Graphical Abstract 1 Introduction Neurological conditions, including central nervous system (CNS) disorders, have emerged as the leading cause of illness and disability worldwide, affecting more than 3 billion individuals more than one-third of the global population based on a study in 2021 (GBD, 2021 Nervous System Disorders Collaborators, 2024)
When to seek medical attention Seek immediate medical care for: Any signs of severe allergic reaction Fever with injection site infection signs Chest pain or significant cardiovascular symptoms Severe or persistent neurological symptoms Any symptom that feels like a medical emergency Seek prompt (but not emergency) medical attention for: Symptoms that persist beyond two weeks without improvement Symptoms that progressively worsen rather than improve New symptoms that appear after initial adjustment period Any symptom that significantly impairs daily function Do not let concern about discussing peptide use prevent you from seeking appropriate care
